Clinical Studies

The BEAR Implant is FDA approved for commercial use, and Miach continues to expand the base of evidence through two post-market studies.

BEAR III

All participants will receive the BEAR Implant to treat their ACL tear. This study is enrolling 250 participants who:

  • Are 12-80 years of age
  • Had an ACL tear within 50 days of the expected surgery date
  • Have a BMI less than 35 kg/m2
Learn More

BEAR MOON

Participants will be randomized to either the BEAR Implant or ACL reconstruction. This NIH-funded study is enrolling 200 participants who:

  • Are 18-40 years of age
  • Had a complete ACL tear within 50 days of the expected surgery date
  • Have a BMI less than 35 kg/m2
Learn More

If you would like to refer a patient for participation in a BEAR Implant clinical trial, contact the nearest investigator on the map below.